BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26769658)

  • 1. Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence.
    Fouda AY; Artham S; El-Remessy AB; Fagan SC
    Clin Sci (Lond); 2016 Feb; 130(4):221-38. PubMed ID: 26769658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.
    Borghi C; ; Rossi F;
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):429-44. PubMed ID: 26403596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
    Giles TD
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence.
    Kangussu LM; Marzano LAS; Souza CF; Dantas CC; Miranda AS; Simões E Silva AC
    Protein Pept Lett; 2020; 27(6):463-475. PubMed ID: 31849284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
    Mogi M; Horiuchi M
    Geriatr Gerontol Int; 2013 Jan; 13(1):13-8. PubMed ID: 22726823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
    Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
    Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The depressor axis of the renin-angiotensin system and brain disorders: a translational approach.
    Gironacci MM; Vicario A; Cerezo G; Silva MG
    Clin Sci (Lond); 2018 May; 132(10):1021-1038. PubMed ID: 29802208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond.
    Clermont A; Bursell SE; Feener EP
    J Hypertens Suppl; 2006 Mar; 24(1):S73-80. PubMed ID: 16601577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition.
    Sullivan JC
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1220-6. PubMed ID: 18287217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of RAS modification for primary and secondary stroke prevention.
    Fintel DJ
    Postgrad Med; 2009 Jul; 121(4):115-22. PubMed ID: 19641277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Brain Angiotensin System Blockade as a Novel Drug Target in Pharmacological Treatment of Neuropsychiatric Disorders.
    Wincewicz D; Braszko JJ
    Pharmacopsychiatry; 2017 Nov; 50(6):233-247. PubMed ID: 28641333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of Angiotensin II receptor blockers in brain disorders.
    Saavedra JM
    Pharmacol Res; 2017 Nov; 125(Pt A):91-103. PubMed ID: 28711402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review.
    Sjølie AK; Dodson P; Hobbs FR
    Int J Clin Pract; 2011 Feb; 65(2):148-53. PubMed ID: 21235695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The retinal renin-angiotensin system: roles of angiotensin II and aldosterone.
    Wilkinson-Berka JL; Agrotis A; Deliyanti D
    Peptides; 2012 Jul; 36(1):142-50. PubMed ID: 22537944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system blocking drugs.
    Robles NR; Cerezo I; Hernandez-Gallego R
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature.
    Fletcher EL; Phipps JA; Ward MM; Vessey KA; Wilkinson-Berka JL
    Prog Retin Eye Res; 2010 Jul; 29(4):284-311. PubMed ID: 20380890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.